(Z)-FeCP-oxindole is a selective inhibitor of human vascular endothelial growth factor receptor 2 (VEGFR2/KDR/Flk-1) with an IC50 value of 200 nM; it significantly inhibits VEGFR1/Flt-1 and PDGFRα or β at 10 μM; it exhibits anticancer activity against B16 murine melanoma cells with an IC50 < 1 μM.